Yaohai Bio-Pharma will participate in Swiss Biotech Day 2026, one of Europe’s most influential biotechnology events. The conference will take place on May 4–5, 2026, at the Congress Center Basel, Switzerland.
During the event, visitors are invited to connect with Yaohai Bio-Pharma at Booth 114, Hall 4.0. Yaohai will present its end-to-end microbial CRDMO solutions designed to accelerate pharmaceutical development from early-stage research through commercial GMP production.
Showcasing End-to-End Microbial CRDMO Capabilities
At Swiss Biotech Day 2026, Yaohai Bio-Pharma will highlight its integrated microbial CRDMO platform. This platform supports drug development across the full lifecycle, from discovery to commercialization.
Specifically, Yaohai provides seamless services that improve speed, scalability, and cost efficiency. As a result, biotech and pharmaceutical companies can move their programs forward with greater confidence and flexibility.
Key capabilities include:
• Recombinant proteins & peptides
• Nucleic acid therapeutics
• Nanobodies
• Plasmid DNA
• Innovative vaccines
In addition, Yaohai leverages advanced microbial expression systems to deliver high-yield and reliable manufacturing solutions. These systems play an increasingly important role in modern biologics production, especially when speed and cost are critical.
Connect with Yaohai Bio-Pharma in Basel
By exhibiting at Booth 114, Hall 4.0, Yaohai Bio-Pharma aims to strengthen its global partnerships and expand its presence in the European biotech ecosystem.
Visitors will have the opportunity to:
- Meet Yaohai’s scientific and business development experts
- Explore customized CRDMO solutions
- Discuss project needs from early research to GMP manufacturing
- Identify opportunities for long-term collaboration
Furthermore, the company welcomes both existing partners and new contacts to schedule meetings during the event and explore how microbial platforms can accelerate development timelines.
About Swiss Biotech Day
Swiss Biotech Day is a leading European biotechnology conference organized by the Swiss Biotech Association. It focuses on fostering international collaboration and innovation across the life sciences sector. The two-day event includes exhibitions, keynote sessions, and partnering meetings, creating a dynamic environment for companies across the biotech value chain.
About Yaohai Bio-Pharma
Yaohai Bio-Pharma is a CRDMO with extensive expertise in microbial expression systems. We focus on recombinant proteins, nucleic acid drugs, nanobodies, plasmid DNA, and innovative vaccines. From R&D to commercial manufacturing, we offer full-lifecycle solutions. Our mission is to build an open, integrated CRO/CDMO/MAH platform that supports global partners from discovery to market.
